한글목차

세계의 유전학적 검사 시장은 2024년에는 65억 4,000만 달러로 평가되었고, 2030년에는 102억 6,000만 달러에 이를 전망이며, 예측 기간 동안 CAGR 7.79%로 성장할 것으로 예측됩니다.

유전학적 검사는 많은 유전성 질환의 검출, 진단, 예방을 가능하게 하는 것으로, 현대의 헬스케어를 크게 변혁해 왔습니다. 유전자 검사 또는 DNA 검사로도 알려진 이 과정은 유전성 질환과 관련된 변이를 특정하기 위해 개인의 DNA를 검사하는 것을 포함합니다. 낭포성 섬유증이나 특정 암과 같은 질환의 진단부터 가족계획에 대한 정보 제공, 개인의 유전자 프로파일에 기초한 약물 요법의 조정까지 그 용도 범위는 다양합니다. 유전체학과 바이오테크놀로지의 급속한 진보에 힘입은 유전적 건강에 대한 의식의 고조가 보급을 뒷받침하고 있습니다. 임상적인 유용성과 더불어 많은 소비자들이 조상의 핏줄을 알아보고 유전적 유산을 이해하기 위해 유전학적 검사를 활용하고 있어 보다 광범위한 시장 확대에 기여하고 있습니다.

시장 성장 촉진요인

유전성 질환의 유병률 증가가 세계 유전학적 검사 시장 견인

주요 시장 과제

윤리 및 프라이버시에 대한 우려

주요 시장 동향

기술 진보

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 유전학적 검사 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 질환별(유전성 암 검사, 유전성 비암 검사)
  • 기술별(세포유전학, 생화학, 분자검사)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 유전학적 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 유전학적 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 유전학적 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 유전학적 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 유전학적 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병 및 인수
• 제품 개발
• 최근 동향

제13장 세계의 유전학적 검사 시장 : SWOT 분석

제14장 경쟁 구도

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

제15장 전략적 제안

제16장 기업 소개 및 면책사항

영문목차

The Global Hereditary Testing Market was valued at USD 6.54 billion in 2024 and is projected to reach USD 10.26 billion by 2030, growing at a CAGR of 7.79% during the forecast period. Hereditary testing has significantly transformed modern healthcare by enabling the detection, diagnosis, and prevention of numerous inherited conditions. Also known as genetic or DNA testing, this process involves examining an individual's DNA to identify mutations linked to hereditary diseases. Applications range from diagnosing conditions like cystic fibrosis and certain cancers to informing family planning and tailoring drug therapies based on individual genetic profiles. The surge in awareness around genetic health, supported by rapid advancements in genomics and biotechnology, is driving widespread adoption. In addition to clinical utility, many consumers are leveraging hereditary testing to explore ancestry and understand genetic heritage, contributing to broader market expansion.

Key Market Drivers

Increasing Prevalence of Genetic Disorders is Driving Global Hereditary Testing Market

The rising incidence of genetic disorders is a primary force behind the growth of the hereditary testing market. As the global population ages, the likelihood of developing hereditary conditions increases, prompting a need for early detection and proactive healthcare. Enhanced research and discovery of genetic markers are broadening the spectrum of diseases for which testing is recommended. Prospective parents are increasingly turning to carrier screening to identify potential hereditary risks to their children, fostering informed reproductive choices. Additionally, genetic testing is gaining traction in assessing susceptibility to hereditary cancers such as breast and colon cancer, enabling timely preventive actions and regular screenings. The expanding understanding of genetics and heightened public awareness are fueling demand for these tests, positioning hereditary testing as a cornerstone of modern personalized medicine.

Key Market Challenges

Ethical and Privacy Concerns

One of the major challenges in the hereditary testing market is the ethical and privacy concerns surrounding genetic data. Individuals are often wary of how their sensitive genetic information is collected, stored, and shared. Risks such as data breaches, unauthorized access, and potential discrimination by employers or insurers create apprehension among users. This has led to increasing calls for stricter data protection laws and transparent policies that ensure confidentiality and responsible usage of genetic information. Addressing these concerns is essential for maintaining public trust and encouraging broader adoption of hereditary testing services.

Key Market Trends

Technological Advancements

The hereditary testing market is being rapidly transformed by technological innovations that are enhancing the speed, affordability, and scope of genetic analysis. One of the most impactful advancements is the widespread adoption of Next-Generation Sequencing (NGS), which allows for efficient and cost-effective sequencing of entire genomes or specific gene panels. This has significantly expanded testing capabilities, making it possible to detect rare mutations and gain deeper insights into genetic predispositions. Additionally, the integration of big data analytics and advanced bioinformatics has revolutionized the interpretation of complex genetic data. These tools enable healthcare providers to identify meaningful patterns and correlations, improving diagnostic accuracy and enabling more precise treatment plans. As these technologies evolve, they are expected to drive further innovation and accessibility in the hereditary testing landscape.

Key Market Players

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

Report Scope:

In this report, the Global Hereditary Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hereditary Testing Market, By Disease Type:

• Hereditary Cancer Testing
• Hereditary Non-cancer Testing

Hereditary Testing Market, By Technology:

• Cytogenetic
• Biochemical
• Molecular Testing

Hereditary Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hereditary Testing Market.

Available Customizations:

Global Hereditary Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Hereditary Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing)
  • 5.2.2. By Technology (Cytogenetic, Biochemical, Molecular Testing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Hereditary Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Technology
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hereditary Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Technology
  • 6.3.2. Canada Hereditary Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Technology
  • 6.3.3. Mexico Hereditary Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Technology

7. Europe Hereditary Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hereditary Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Technology
  • 7.3.2. United Kingdom Hereditary Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Technology
  • 7.3.3. Italy Hereditary Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Technology
  • 7.3.4. France Hereditary Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Technology
  • 7.3.5. Spain Hereditary Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Technology

8. Asia-Pacific Hereditary Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Hereditary Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Technology
  • 8.3.2. India Hereditary Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Technology
  • 8.3.3. Japan Hereditary Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Technology
  • 8.3.4. South Korea Hereditary Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Technology
  • 8.3.5. Australia Hereditary Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Technology

9. South America Hereditary Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hereditary Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Technology
  • 9.3.2. Argentina Hereditary Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Technology
  • 9.3.3. Colombia Hereditary Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Technology

10. Middle East and Africa Hereditary Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hereditary Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Technology
  • 10.3.2. Saudi Arabia Hereditary Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Technology
  • 10.3.3. UAE Hereditary Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Hereditary Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Myriad Genetics, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Illumina, Inc.
• 14.3. Natera, Inc.
• 14.4. Laboratory Corporation of America Holdings
• 14.5. F. Hoffmann-La Roche Ltd.
• 14.6. Quest Diagnostics Incorporated
• 14.7. COOPERSURGICAL, INC.
• 14.8. Agilent Technologies, Inc.
• 14.9. Thermo Fisher Scientific, Inc.
• 14.10. SOPHiA GENETICS

15. Strategic Recommendations

16. About Us & Disclaimer